Cell therapy bioprocessing

CELL AND GENE THERAPY INSIGHTS

November 2022

Cell therapy bioprocessing

Expert Roundtable

AAV process development & scale-up

AAV process development & scale-up

Catherine Cancian, Karen Doucette, Reinout Hesselink

Commentary

Cell therapy 101 (part 1)Challenges of early clinical development: a ‘thumbnail sketch’

Cell therapy 101 (part 1)Challenges of early clinical development: a ‘thumbnail sketch’

29 November 2022

FastFacts

A flexible & fully automated process for CAR T cell manufacturing

A flexible & fully automated process for CAR T cell manufacturing

11 November 2022

Standardizing flow cytometric assays during cell manufacturing

Standardizing flow cytometric assays during cell manufacturing

3 November 2022

Viewpoint

Key considerations for early investment in the process development of cell-based therapeutics

Key considerations for early investment in the process development of cell-based therapeutics

Kelly Kemp, Sebastian Rieck

23 November 2022

Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products

Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products

William E Janssen, Scott R Burger

2 November 2022

Interview

Enabling GMP-ready cell sorting for cell and gene therapy manufacturing

Enabling GMP-ready cell sorting for cell and gene therapy manufacturing

8 February 2023

Advancing cell therapy manufacturing towards industry 4.0

Advancing cell therapy manufacturing towards industry 4.0

Thomas Bollenbach

21 November 2022

Enabling scalable manufacture of exosomes for future clinical & commercial requirements

Enabling scalable manufacture of exosomes for future clinical & commercial requirements

22 October 2022

Webinars

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Tracy Moore, Delara Motlagh

11 January 2022

The next generation of GMP cell sorting - high-throughput, sterile, scalable

The next generation of GMP cell sorting - high-throughput, sterile, scalable

Samson Rogers PhD

11 October 2022

Industrialization of cell and gene therapies: process development best practices for commercialization readiness

Industrialization of cell and gene therapies: process development best practices for commercialization readiness

Behnam Ahmadian Baghbaderani

17 November 2022

Let the cells thrive - The next generation of cell expansion

Let the cells thrive - The next generation of cell expansion

H Fabre, M Barbisin, M Knaub

22 November 2022

Extracellular Vesicles: From Waste EVictees to Therapeutic Reality

Extracellular Vesicles: From Waste EVictees to Therapeutic Reality

Amy Kauffman

30 November 2022

How to secure and standardize your cell expansion

How to secure and standardize your cell expansion

Anette Brass, Paula Villaescusa Sánchez

6 December 2022

Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Sung Lee, Deepak Kumar

8 December 2022